#non-Hodgkin's lymphoma

CAR-T Therapy: Lifeline to A Cure?

Toby Keith, Robin Roberts, Jeff Bridges and more share their cancer stories.

As the new editor-in-chief of Cancer Health, Trent Straube is honored to amplify stories of survivors, families, advocates and more.

“This is a very treatable cancer,” says Oscar-winning actress Jane Fonda, who will start chemotherapy for non-Hodgkin lymphoma.

A new report stresses the need for better access to health insurance coverage to improve cancer care and outcomes.

“COVID made my cancer look like nothing,” actor Jeff Bridges, famous as the Dude and now starring in “The Old Man,” tells EW.

A new study finds that Medicaid expansion increases survival and reduces health disparities for newly diagnosed patients with cancer.

The personalized CAR-T therapy prolonged cancer remission compared with standard therapy.

Researchers are examining opportunities for immune-modulating approaches to improve outcomes and reduce side effects.

People with blood cancers and those on chemotherapy may not respond adequately to their first two vaccine doses.

Improved detection methods could make a world of difference for patients undergoing cancer therapy.

A study from the Leukemia & Lymphoma Society finds that antibody production varies widely across blood cancer types.

Zynlonta led to complete remission in nearly a quarter of patients with large B-cell lymphoma.

After a median follow-up of 13 months, four of the five patients had ongoing complete remission.

After approval of the latest cellular therapy for non-Hodgkin lymphoma, the big challenge is how to extend it to common solid tumors.

Half of patients treated with Breyanzi experienced complete remission, and a majority of these responses were durable.